Avita Medical | صافي الدخل


Net Income تغيير تاريخ
Adcock Ingram Holdings ZAR 389.71M 19.87M 2024-12
Celltrion KRW 108.67B 127.98B 2025-03
Clinuvel Pharmaceuticals AUD 24.7M 13.76M 2024-06
Cochlear AUD 205.1M 39.7M 2024-12
CSL USD 2.01B 1.27B 2024-12
Cspc Pharmaceutical CNY 1.48B 927.97M 2025-03
Dianthus Therapeutics USD -31629000 3.19M 2025-06
Divis Laboratories Ltd 5.45B 1.17B 2025-06
Kangmei Pharma CNY 8.4M 110.17K 2025-06
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 21.64M 70.9M 2025-06
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD -103681000 68.4M 2024-06
Medical Developments International AUD 304K 15.32M 2024-12
Nanosonics AUD 9.76M 6.36M 2024-12
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Organigram Holdings CAD -6290000 16.67M 2025-06
Pacific Edge NZD -14503000 7.36M 2024-09
Paradigm Biopharmaceuticals AUD -5924050 3.77M 2024-12
Pharma Mar EUR 23.37M 27.32M 2025-06
Polynovo AUD 1.28M 1.41M 2024-06
PYC Therapeutics AUD -25572620 14.25M 2024-12
Qiagen NV USD 96.25M 5.49M 2025-06
Ramsay Health Care AUD -104900000 235.1M 2024-12
ResMed USD 379.7M 35.08M 2025-06
Sartorius EUR 32.5M 15.9M 2025-06
Sino Biopharmaceutical CNY 482.67M 2.53B 2024-12
Telix Pharmaceuticals AUD 10.13M 19.52M 2024-12
Tilray USD -85342000 46.18M 2024-11
Zz Pientze Pharmaceu 442.53M 557.25M 2025-06


Avita Medical صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.